Cargando…

Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries

Regulators and pharmaceutical companies across the world are intensifying efforts to get increasingly complex and innovative drugs to patients with high unmet medical need in the shortest possible time frame. This article reviews pathways to expedite drug development and approval available in member...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco, Pedro, Jain, Ritesh, Rosenkrands-Lange, Elizabeth, Hey, Claudia, Koban, Marén U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734413/ https://www.ncbi.nlm.nih.gov/pubmed/36463352 http://dx.doi.org/10.1007/s43441-022-00480-3

Ejemplares similares

Expedited regulatory product approval in the time of COVID-19
por: Novack, Gary D.
Publicado: (2022)

Proposal of International Council for Harmonization (ICH) Guideline for the Approval of Biosimilars
por: Niazi, Sarfaraz K., et al.
Publicado: (2022)

Use of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeutics
por: Wong, Alissa K., et al.
Publicado: (2023)

Expedited approval system for regenerative medicine products – Is it unusual?
por: Yano, Kazuo, et al.
Publicado: (2016)

The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine
por: Kantor, Ariel, et al.
Publicado: (2021)

FDA expedited approval and implications for rational formulary and health plan design
por: Ferries, Erin A, et al.
Publicado: (2021)

„Wenn ich groß bin, geh‘ ich in die Pflege“
por: Jerusalem, Anna, et al.
Publicado: (2022)

Safety related label changes for new drugs after approval in the US through expedited regulatory pathways: retrospective cohort study
por: Mostaghim, Sana R, et al.
Publicado: (2017)

Kampagne „ICH SEH, ICH SEH“ macht auf Diabetes aufmerksam
Publicado: (2020)

"Wehe, wenn ich erzähle, wehe, wenn ich nicht erzähle"
por: Zwipp,, Hans
Publicado: (2023)

Regulatory Affairs 101: Introduction to Expedited Regulatory Pathways
por: Cox, Erica M., et al.
Publicado: (2020)

Ich wíinikil : Intus decretum
por: Calderón Martín, Argelia Cuautlehuanitzin
Publicado: (2012)

Was ich sagen wollte /
por: Radecki, Sigismund von

Expedited approval of cancer drugs without randomized controlled trials: Too good to be true?
por: Shepshelovich, Daniel, et al.
Publicado: (2018)

"Als Controller weiß ich oft mehr, als ich selbst kommunizieren darf"
por: Schäffer, Utz
Publicado: (2021)

Prospects for Psychological Support in Interplanetary Expeditions
por: Gushin, Vadim, et al.
Publicado: (2021)

Ich wíinikil-Intus decretum
por: Riveros Elox, José Ricardo
Publicado: (2012)

"Ich bin keine boss"
por: Cerutti, H
Publicado: (1992)

Bitte, was habe ich davon?
Publicado: (2008)

Natürlich habe ich Träume
Publicado: (2008)

Revision of ICH S8 Needed?
por: Van Der Laan, Jan Willem
Publicado: (2022)

24-Hour ICH Score Is a Better Predictor of Outcome than Admission ICH Score
por: Aysenne, Aimee M., et al.
Publicado: (2013)

Total Burden of Cerebral Small Vessel Disease in Recurrent ICH versus First-ever ICH
por: Xu, Mangmang, et al.
Publicado: (2019)

Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation
por: Mercuri, Mathew, et al.
Publicado: (2023)

Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study
por: Kesselheim, Aaron S, et al.
Publicado: (2015)

The FDA’s New Guideline “Generally Accepted Scientific Knowledge” (GASK): An Opportunity to Expedite the Approval of Biosimilars
por: Niazi, Sarfaraz K.
Publicado: (2023)

Commentary: Expedited Regulatory Review of Low-Value Drugs
por: Darrow, Jonathan J., et al.
Publicado: (2020)

Few new drugs deserve expedited regulatory treatment
por: Darrow, Jonathan J
Publicado: (2021)

Reasons for medical consultation among members of the Indian Scientific Expeditions to Antarctica
por: Bhatia, Abhijeet, et al.
Publicado: (2013)

Predicting Prognosis of Intracerebral Hemorrhage (ICH): Performance of ICH Score Is Not Improved by Adding Oral Anticoagulant Use
por: Houben, Rik, et al.
Publicado: (2018)

Kommentar II zum Fall: „Eine Patientenverfügung brauche ich nicht, ich will nicht abgeschaltet werden“
por: Spickhoff, Andreas
Publicado: (2022)

ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries
por: Miranda, Claudia, et al.
Publicado: (2021)

Ich muss mir 'Illuminati' anschauen
Publicado: (2009)

"Ich konnte einfach nicht aufhören"
Publicado: (2020)

"Ich spritze dieses Jahr nicht"
por: Pfitzer, Joachim
Publicado: (2021)

New Prediction Models of Functional Outcome in Acute Intracerebral Hemorrhage: The dICH Score and uICH Score
por: Yang, Wen-Song, et al.
Publicado: (2021)

Expedition
Publicado: (1959)

Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries
por: Durán, Carlos E., et al.
Publicado: (2021)

Corrigendum: New Prediction Models of Functional Outcome in Acute Intracerebral Hemorrhage: The dICH Score and uICH Score
por: Yang, Wen-Song, et al.
Publicado: (2022)

Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union
por: Jokura, Yoji, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nta4inmf6fk433roc18udl1pl4